# Efficacy and Safety of Stellate Ganglion Block With Lidocaine Combined Platelet-rich Plasma to Treat Chronic Migraine

> **NCT06653218** · — · COMPLETED · sponsor: **Beijing Tiantan Hospital** · enrollment: 200 (actual)

## Conditions studied

- Platelet-rich Plasma
- Chronic Migraine

## Interventions

- **OTHER:** No interventions
- **OTHER:** Not have interventions

## Key facts

- **NCT ID:** NCT06653218
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-20
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06653218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06653218, "Efficacy and Safety of Stellate Ganglion Block With Lidocaine Combined Platelet-rich Plasma to Treat Chronic Migraine". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06653218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*